首页 > 专家库
李姗姗

领域:生物产业 学校:西南大学职称:副教授

大环化合物药物制剂应用...

具体了解该专家信息,请致电:027-87555799 邮箱 haizhi@uipplus.com

教育背景

2017/02-2018/02 墨尔本大学 化学工程学院,联合培养博士 2009/09-2018/07 四川大学,化学工程学院,本硕博“3+2+3”连读

工作经历

2018/07-至今 西南大学,药学院·中医药学院,制药工程系,副教授

项目课题经历

论文、成果、著作等

论文发表 [1] Q. Zhang1, F. Zhang1, S. Li1, R. Liu, T. Jin, Y. Dou, Z. Zhou*, J. Zhang*. A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment, Theranostics, 2019, 9(13): 3732-3753. [2] S. Niu, W. Ma, M. Jin, J. Chen, S. Li*, X. Zou*. Complete Genome Sequence of Kosakonia sp. Strain CCTCC M2018092, a Fucose-Rich Exopolysaccharide Producer, Microbiology Resource Announcements, 2019, 8: e00567-19. [3] S. Li1, X. Lin, K. Xu, J. He, H. Yang, H. Li*. Co-grinding effect on crystalline zaltoprofen with β-cyclodextrin/cucurbit[7]uril in tablet formulation, Scientific Reports, 2017, 7: 45984. [4] S. Li1, J. He, Y. Huang, Q. Wang, H. Yang, K. Xu, H. Li*. Interactions of cucurbit[6,7]urils with human serum albumin and their effects on zaltoprofen transportation, RSC Advances, 2016, 6: 85811–85819. [5] S. Li1, Y. Zhai, J. Yan, L. Wang, K. Xu, H. Li*. Effect of preparation processes and structural insight into the supermolecular system: Bisacodyl and β-cyclodextrin inclusion complex, Materials Science and Engineering C, 2016, 58: 224–232. [6] S. Li1, L. Wang, J. Jiang, P. Tang, Q. Wang, D. Wu, H. Li*. Investigations of bisacodyl with modified β-cyclodextrins: Characterization, molecular modeling, and effect of PEG, Carbohydrate Polymers, 2015, 134: 82–91. [7] S. Li1, X. Wu, Q. Pan, Q. Cheng, H. Li*. Comparison of the accuracy of powder and single-crystal X-ray diffraction techniques in determining organic crystal structure, Chinese Science Bulletin, 2014, 59: 497–501. [8] S. Li1, X. Wu, Q. Wang, P. Tang, H. Li*. X-ray powder diffraction data for bisacodyl, C22H19NO4, Powder Diffraction, 2014, 29: 295–297.

专利、著作版权等

声明:本站专家信息来源于各高校官网。